Search
for
Sort by
Research 301–330 of 1000+
- Steroid Hormones
- The genetically programmed hair growth cycle and alopecia: what is there to know?
- Dermatopathology of Common Hair Problems
- Cytokines
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- A CLINICAL STUDY OF CUTANEOUS MANIFESTATIONS IN PATIENTS WITH THYROID DISORDERS
- Acne and acneiform eruptions
- Role of Dermal Melanocytes in Cutaneous Pigmentation of Stasis Dermatitis
- Effectiveness of Radiofrequency Microneedling in the Treatment of Dermatological Conditions: A Systematic Review
- A symphony of signals: the intricate role of lncRNAs in dermatological disorders
- Managing Menopausal Skin: A Clinician’s Review
- Janus Kinase inhibitors in dermatology: a review
- Treatments for alopecia areata: a network meta-analysis
- Pharmacological Treatment of Alopecia
- Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
- Alternative Medicine for Hair Loss
- Antihelminthic Drugs
- Cutaneous drug reactions
- Cicatricial Alopecia
- Dermatological drugs, topical agents, and cosmetics
- Perspectives on Dermatopathology
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Follicular Atopic Dermatitis in Dark Skin
- Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia
- Narrative Review of Skin and Pregnancy: Dermatologic Manifestations and Medication Management During Pregnancy
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Exploring the therapeutic potential of naturally occurring taxifolin, a dietary flavonoid: an updated comprehensive review
- Novel drugs of United States Food and Drug Administration approved in 2024